Oncology Data Advisor

Additional Advances in Newly Diagnosed Multiple Myeloma: Interview + Free CPE Podcast

11.03.2023 - By i3 HealthPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this interview, Dr. Joseph Kalis, Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health, speaks with i3 Health and the Pharmacy Podcast Network to share an exclusive preview of the recent CPE activity that he developed with i3 Health, Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma. After the interview, stay tuned to hear the full presentation from Dr. Kalis and his co-chair, Dr. Eric Cannon, Chief Pharmacy Benefits Officer at SelectHealth, and claim free CPE credit for the activity at https://bit.ly/45WA5hR.

-----

DISCLOSURE OF RELEVANT FINANCIAL INFORMATION WITH INELIGIBLE COMPANIES

i3 Health and St. John Fisher University Wegmans School of Pharmacy (WSOP) endorse the standards of the ACPE that require everyone in a position to control the content of a CPE activity to disclose all financial relationships with ineligible companies that are related to the content of the CPE activity. CPE activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when an individual has an opportunity to affect CPE content about products or services of an ineligible company with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.

i3 Health and St. John Fisher University Wegmans School of Pharmacy (WSOP) will identify, review, and mitigate all relevant financial relationships that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health and St. John Fisher University Wegmans School of Pharmacy (WSOP) does not endorse any products or services.

Relevant financial relationships exist between the following individuals and ineligible companies:

The i3 Health planners, reviewers, and managers have nothing to disclose.

St. John Fisher University Wegmans School of Pharmacy (WSOP) staff members have no relevant financial relationships to disclose.

Eric Cannon, PharmD, FAMCP, has no relevant financial relationships to disclose.

Joseph A. Kalis, PharmD, BCOP, has no relevant financial relationships to disclose.

i3 Health has mitigated all relevant financial relationships.

More episodes from Oncology Data Advisor